financetom
Business
financetom
/
Business
/
Linde's Q4 Adjusted Earnings Rise, Sales Decline; Issues Q1, 2025 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Linde's Q4 Adjusted Earnings Rise, Sales Decline; Issues Q1, 2025 Outlook
Feb 6, 2025 3:48 AM

06:29 AM EST, 02/06/2025 (MT Newswires) -- Linde ( LIN ) reported Q4 adjusted earnings Thursday of $3.97 per diluted share, up from $3.59 a year earlier.

Analysts polled by FactSet expected $3.94.

Sales for the quarter ended Dec. 31 were $8.28 billion, compared with $8.30 billion a year earlier.

Analysts surveyed by FactSet expected $8.42 billion.

The company said it expects Q1 adjusted EPS of $3.85 to $3.95. Analysts surveyed by FactSet expect $3.97.

For the full year, Linde ( LIN ) expects adjusted EPS of $16.15 to $16.55. Analysts surveyed by FactSet expect $16.81.

The company shares were down over 5% in recent premarket activity.

Price: 430.01, Change: -23.69, Percent Change: -5.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pulse Biosciences Appoints Burke Barrett as President, CEO
Pulse Biosciences Appoints Burke Barrett as President, CEO
May 14, 2024
05:17 PM EDT, 05/14/2024 (MT Newswires) -- Pulse Biosciences ( PLSE ) said late Tuesday it has appointed Burke T. Barrett as president and chief executive, effective immediately, succeeding Kevin Danahy. Danahy has been appointed as the company's chief commercial officer. ...
3M shareholders vote down executives' pay packages in annual meeting
3M shareholders vote down executives' pay packages in annual meeting
May 14, 2024
(Reuters) - 3M ( MMM ) said on Tuesday that the annual compensation packages of certain executives, including that of former CEO Mike Roman, did not receive the requisite number of favorable shareholder votes, on an advisory basis. Roman's 2023 total compensation was $16.4 million, compared to about $14 million in 2022, even as the company dealt with the fallout...
Ginkgo Bioworks Holdings Insider Sold Shares Worth $1,606,162, According to a Recent SEC Filing
Ginkgo Bioworks Holdings Insider Sold Shares Worth $1,606,162, According to a Recent SEC Filing
May 14, 2024
05:17 PM EDT, 05/14/2024 (MT Newswires) -- Marijn E Dekkers, Director, on May 14, 2024, sold 1,727,056 shares in Ginkgo Bioworks Holdings ( DNA ) for $1,606,162. Following the Form 4 filing with the SEC, Dekkers has control over a total of 6,061,581 shares of the company, with 281,217 shares held directly and 5,780,364 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1830214/000112760224015293/xslF345X03/form4.xml ...
Credo Technology Group Holding Insider Sold Shares Worth $958,397, According to a Recent SEC Filing
Credo Technology Group Holding Insider Sold Shares Worth $958,397, According to a Recent SEC Filing
May 14, 2024
05:18 PM EDT, 05/14/2024 (MT Newswires) -- Chi Fung Cheng, Director, Chief Technology Officer, on May 10, 2024, sold 55,000 shares in Credo Technology Group Holding ( CRDO ) for $958,397. Following the Form 4 filing with the SEC, Cheng has control over a total of 9,857,426 shares of the company, with 138,824 shares held directly and 9,718,602 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved